Navigation Links
Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
Date:5/8/2008

cal disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. To be properly diagnosed with ADHD, a child needs to demonstrate at least six of nine symptoms of inattention; and/or at least six of nine symptoms of hyperactivity/impulsivity; the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and home); that the symptoms continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be better explained by another psychiatric disorder.

Although there is no "cure" for ADHD, there are accepted treatments that specifically target its symptoms. The most common standard treatments include educational approaches, psychological or behavioral modification, and medication.

About VYVANSE

Tell the doctor about any heart conditions, including structural abnormalities, that you, your child, or a family member, may have. Inform the doctor immediately if you or your child develops symptoms that suggest heart problems, such as chest pain or fainting.

Vyvanse should not be taken if you or your child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; glaucoma; a history of problems with alcohol or drugs; agitated states; taken a monoamine oxidase inhibitor (MAOI) within the last 14 days.

Tell the doctor before taking Vyvanse if you or your child is being treated for or has symptoms of depression (sadness, worthlessness, or hopelessness) or bipolar disorder; has abnormal thought or visions, hea
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)...  Salix Pharmaceuticals, Ltd. (the " Company " or ... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX:VRX), today ... Changes, Make-Whole Fundamental Changes and Merger Event, Fundamental Change ... Offer to Purchase (the " Notice ") to holders ... " Notes "), pursuant to the Indenture, dated as ...
(Date:4/1/2015)... 2015 Trinity Biotech plc (Nasdaq: ... diagnostic products for the point-of-care and clinical laboratory ... its wholly-owned subsidiary (the "Issuer"), intends to offer, ... aggregate principal amount of Exchangeable Senior Notes due ... buyers pursuant to Rule 144A under the Securities ...
(Date:4/1/2015)...  Pittman Motors has significantly expanded its gearbox ... PLG52, and PLG63 planetary gearboxes. These gearboxes are ... motors and complement Pittman,s existing spur and planetary ... motor-gearbox family combinations to the Pittman offerings. ... loads with excellent efficiency and are small, durable, ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 7Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Pittman Motors Expands PLG Planetary Gearbox Offering 2
... -- Pharmaceutical company Hatchtech Pty Ltd has completed treatment ... confirm the efficacy of its novel head lice treatment ... the efficacy, safety and tolerability of two dose levels ... The trial consists of treating 132 healthy subjects with ...
... LYNBROOK, N.Y., Aug. 31, 2011 Auxilium Pharmaceuticals, Inc. ... and BioSpecifics Technologies Corp. (NASDAQ: BSTC ), ... all pending litigation between the Companies and announced plans ... and human and canine lipoma as well as to ...
Cached Medicine Technology:Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™ 2Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™ 3Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 2Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 3Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 4Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 5Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 6Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 7Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX® 8
(Date:4/1/2015)... 01, 2015 The Path Adventures has recently ... adventure you could ever embark upon. Trips range from a ... the Philippine Department of Tourism, these trips are not to ... very few people have ever been in virgin (uninhabited by ... with nothing more than a backpack full of supplies, adventure ...
(Date:4/1/2015)... 2015 New Jersey Governor First ... First Spouses from across the country in sponsoring ... 2015, World Down Syndrome Day(WDSD), to increase awareness ... area of Down syndrome cognition research. , In ... Alaska, American Samoa, Arizona, California, Colorado, Delaware, Florida, ...
(Date:4/1/2015)... April 01, 2015 Taking an important ... National League for Nursing Commission for Nursing Education Accreditation ... approved the first NLN CNEA Board of Commissioners. Working ... ANEF, the 15-member board will provide leadership and direction ... all accreditation decisions for nursing programs that seek accreditation ...
(Date:4/1/2015)... April 01, 2015 It all began at ... Di Gasbarro, who was on a mission to create a ... simple ingredients that parents could trust. Now, Shoosha Truly Organic ... Organic skincare products, meaning all products contain a minimum 95% ... , Babies’ skin is considered to be 40% thinner than ...
(Date:4/1/2015)... IL, Bethesda, MD, Alexandria, VA (PRWEB) April 01, ... Clinical Pathology (ASCP), the College of American Pathologists ... the American Society of Clinical Oncology (ASCO) today ... on the use of molecular marker testing for ... evidence-based guideline will help establish standard molecular marker ...
Breaking Medicine News(10 mins):Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4
... to improve college biology education by engaging faculty members ... departments approach education. PULSE, which stands for Partnership ... funded by the National Science Foundation (NSF), National Institutes ... (HHMI). Program organizers also announced today that they ...
... Researchers at the University of California, San Diego School ... new biomarker and therapeutic target for pancreatic cancer, an ... method for early detection or therapeutic intervention. The ... Research . Pancreatic ductal adenocarcinoma, or PDAC, is ...
... Solution, to Address Today,s Fragmented U.S. Health Care System, ... the U.S. health care system, a group of rising ... health systems, as originally outlined in the landmark 1967 ... Folsom commission could not be more pertinent to America,s ...
... is possible to lengthen the average life of individuals of ... date, however, this has meant altering the animals, genes permanently ... Researchers at the Spanish National Cancer Research Centre (CNIO), led ... can be extended by the application in adult life of ...
... May 14 (HealthDay News) -- People with HIV/AIDS are four ... those in the general population, a new study finds. ... according to researchers from the University of California, San Francisco ... cardiac death, the heart suddenly and unexpectedly stops beating. ...
... Barbara Bronson Gray HealthDay Reporter , MONDAY, May ... offers yet another reason to congratulate someone who has completed ... longer. An unusual, comprehensive study involving 1.2 million Swedes ... education rather than eight had a lower mortality rate after ...
Cached Medicine News:Health News:National initiative launched to change the way biology departments approach undergraduate education 2Health News:National initiative launched to change the way biology departments approach undergraduate education 3Health News:Early biomarker for pancreatic cancer identified 2Health News:May/June 2012 Annals of Family Medicine tip sheet 2Health News:May/June 2012 Annals of Family Medicine tip sheet 3Health News:May/June 2012 Annals of Family Medicine tip sheet 4Health News:May/June 2012 Annals of Family Medicine tip sheet 5Health News:May/June 2012 Annals of Family Medicine tip sheet 6Health News:May/June 2012 Annals of Family Medicine tip sheet 7Health News:May/June 2012 Annals of Family Medicine tip sheet 8Health News:CNIO scientists successfully test the first gene therapy against aging-associated decline 2Health News:CNIO scientists successfully test the first gene therapy against aging-associated decline 3Health News:People With HIV at Higher Odds of Sudden Cardiac Death 2Health News:A Little More Education, a Little Longer Life? 2Health News:A Little More Education, a Little Longer Life? 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: